The Prevalence of Cancer and Its Relation to Disease Activity in Patients With Acromegaly: Two Centers' Experience
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 27 (1), 51-55
- https://doi.org/10.4158/ep-2020-0398
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Emerging trends in the diagnosis and treatment of acromegaly in CanadaClinical Endocrinology, 2013
- Thyroid cancer is the most common cancer associated with acromegalyPituitary, 2010
- Increased cancer incidence in acromegaly – a nationwide surveyClinical Endocrinology, 2010
- Acromegaly pathogenesis and treatmentJCI Insight, 2009
- Risk of colorectal neoplasm in patients with acromegaly: A meta-analysisWorld Journal of Gastroenterology, 2008
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- Incidence of Malignant Tumors in Patients with AcromegalyEndocrine Journal, 2000
- Increased incidence of neoplasia in patients with pituitary adenomasClinical Endocrinology, 1998
- Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loopInternational Journal of Cancer, 1994